Sign inCreate account

Report workspace tools

NCT00732537COMPLETEDanonymous

Inhaled Nitric Oxide in Neonates With Elevated A-aDO2 Gradients Not Requiring Mechanical Ventilation

Sponsor

Source record

University of Alabama at Birmingham

Phase

Source record

PHASE4

Modality

AI-normalized

small molecule

Target

AI-normalized

inhaled Nitric Oxide, Oxygen (>90% by hood) - standard therapy

Indication / condition

AI-normalized

Respiratory Failure

Intervention

Source record

inhaled Nitric Oxide, Oxygen (>90% by hood) - standard therapy

Source & freshness

Source record

NCT ID

NCT00732537

Original source

ClinicalTrials.gov

Source last updated

Aug 12, 2008

Ingested at

May 21, 2026

Internal sync

May 23, 2026

Model version

trialsignal-ai-v1

Normalized confidence

96%

Validation status

validated

Open original registry record
View original source fields

NCT ID

NCT00732537

Title

Inhaled Nitric Oxide in Neonates With Elevated A-aDO2 Gradients Not Requiring Mechanical Ventilation

Sponsor

University of Alabama at Birmingham

Status

COMPLETED

Phase

PHASE4

Condition raw

Respiratory Failure, Infant, Persistent Fetal Circulation

Condition normalized

Respiratory Failure, Infant, Persistent Fetal Circulation

Modality raw

small molecule

Modality normalized

small molecule

Target raw

inhaled Nitric Oxide, Oxygen (>90% by hood) - standard therapy

Target normalized

inhaled Nitric Oxide, Oxygen (>90% by hood) - standard therapy

Interventions

inhaled Nitric Oxide, Oxygen (>90% by hood) - standard therapy

Public preview

Source record

Inhaled nitric oxide (iNO) improves oxygenation in term infants with respiratory failure. However, iNO has been primarily used in infants receiving mechanical ventilation. This study is a pilot study to determine if iNO given into an oxygen hood is effective in improving oxygenation in term and near-term infants who have poor oxygenation but who are not yet mechanically ventilated.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Full protocol, outcomes, eligibility, contacts and results sections
Patent/IP landscape with verified records when available
Board-ready PDF export with source provenance
Save to folders and synthesize multiple assets in premium workspace
Create account
Sign in

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

Inhaled Nitric Oxide in Neonates With Elevated A-aDO2 Gradients Not Requiring Mechanical Ventilation

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jun 13, 2026

NCT ID

NCT00732537

Status

COMPLETED

Phase

PHASE4

Sponsor

University of Alabama at Birmingham

Executive brief

Investment-Ready Snapshot

Inhaled nitric oxide (iNO) improves oxygenation in term infants with respiratory failure. However, iNO has been primarily used in infants receiving mechanical ventilation. This study is a pilot study to determine if iNO given into an oxygen hood is effective in improving oxygenation in term and near-term infants who have poor oxygenation but who are not yet mechanically ventilated.

Source & freshness

Provenance

SourceClinicalTrials.gov
Source updatedAug 12, 2008
Internal syncMay 23, 2026
Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT00732537

Indication

Respiratory Failure

Modality

small molecule

Target

inhaled Nitric Oxide, Oxygen (>90% by hood) - standard therapy

Intervention

inhaled Nitric Oxide, Oxygen (>90% by hood) - standard therapy

Source record

Protocol Description

Detailed source ingestion pending.

Source record

Outcome Measures

Detailed source ingestion pending.

Source record

Eligibility

Detailed source ingestion pending.

AI analysis

Known Results And Readout Context

Detailed source ingestion pending.

IP intelligence

Patent And IP Landscape

Detailed source ingestion pending.

Source record

Contacts

Detailed source ingestion pending.